Drugs / strontium chloride hexahydrate
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01301677 | Jan → Jun 2011 | — | X-pert Med GmbH | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT00804375 | Dec 2008 → Jun 2010 | — | Smerud Medical Research International AS | Unknown | No outcome recorded |
| Phase 2 | NCT00592098 | Aug → Dec 2007 | congenital amputation | SantoSolve AS | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00954629 | Jun 2009 → May 2010 | osteoarthritis | Smerud Medical Research International AS | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Strontium Chloride Hexahydrate | “strontium chloride hexahydrate in a penetration enhancing vehicle” NCT01301677 ↗ |
| Known as | 2PX | “2PX (Topical Strontium Chloride Hexahydrate)” NCT00954629 ↗ |
| Route | Topical | “Cutaneous solution” NCT00592098 ↗ |